These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 2209697)
1. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules. Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697 [TBL] [Abstract][Full Text] [Related]
2. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules. Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554 [TBL] [Abstract][Full Text] [Related]
3. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Karp DR; Teletski CL; Scholl P; Geha R; Long EO Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209 [TBL] [Abstract][Full Text] [Related]
4. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. Scholl PR; Diez A; Geha RS J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962 [TBL] [Abstract][Full Text] [Related]
5. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064 [TBL] [Abstract][Full Text] [Related]
6. Staphylococcal toxins bind to different sites on HLA-DR. Chintagumpala MM; Mollick JA; Rich RR J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373 [TBL] [Abstract][Full Text] [Related]
7. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules. Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700 [TBL] [Abstract][Full Text] [Related]
8. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules. Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222 [TBL] [Abstract][Full Text] [Related]
9. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules. Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498 [TBL] [Abstract][Full Text] [Related]
10. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells. Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821 [TBL] [Abstract][Full Text] [Related]
11. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens. Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029 [TBL] [Abstract][Full Text] [Related]
12. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality. Kum WW; Laupland KB; Chow AW Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486 [TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1. von Bonin A; Ehrlich S; Malcherek G; Fleischer B Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089 [TBL] [Abstract][Full Text] [Related]
14. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation. Dennig D; O'Reilly RJ J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791 [TBL] [Abstract][Full Text] [Related]
15. Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells. Fuleihan R; Mourad W; Geha RS; Chatila T J Immunol; 1991 Mar; 146(5):1661-6. PubMed ID: 1847171 [TBL] [Abstract][Full Text] [Related]
16. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules. Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966 [TBL] [Abstract][Full Text] [Related]
17. Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin. Uchiyama T; Saito S; Inoko H; Yan XJ; Imanishi K; Araake M; Igarashi H Infect Immun; 1990 Dec; 58(12):3877-82. PubMed ID: 2123824 [TBL] [Abstract][Full Text] [Related]
18. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2. Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035 [TBL] [Abstract][Full Text] [Related]
19. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells. Imanishi K; Igarashi H; Uchiyama T J Immunol; 1990 Nov; 145(10):3170-6. PubMed ID: 2230113 [TBL] [Abstract][Full Text] [Related]
20. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes. Herrmann T; Accolla RS; MacDonald HR Eur J Immunol; 1989 Nov; 19(11):2171-4. PubMed ID: 2599004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]